REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S is based in Colombia, with the head office in Cucuta. The enterprise currently operates in the Diagnostic Imaging Centers sector. Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S was incorporated on April 30, 2014. The company’s latest financial report indicates a net sales revenue drop of 39.64% in 2023. There was a total negative growth of 17.6% in Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S’s total assets over the same period. The net profit margin of Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S decreased by 16.54% in 2023.

Headquarters
Av 0 Nro. 11 - 161 Of 103
Cucuta; Norte de Santander;

Contact Details: Purchase the Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S report to view the information.
Incorporation Date:
April 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Especializado Carlos Montoya & Suarez S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-39.64%
Total operating revenue
-39.64%
Operating profit (EBIT)
-51.65%
Net Profit (Loss) for the Period
-86.4%
Total assets
-17.6%
Total equity
-18.3%
Operating Profit Margin (ROS)
-4.45%
Net Profit Margin
-16.54%
Return on Equity (ROE)
-29.76%
Quick Ratio
-1.27%
Cash Ratio
0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?